Tag: pulmonary embolism

Meta-analysis: IVC filters should be considered for certain patients at high...

In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...
Indigo

EXTRACT-PE trial data confirm Indigo Aspiration system is safe and effective...

Data from the EXRACT-PE trial, published online first in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions, found that the Indigo...

Penumbra’s newest generation of Indigo aspiration system receives FDA clearance for...

Penumbra today announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the latest iteration of the Indigo aspiration system, Lightning...

Similar outcomes for ultrasound-assisted and standard thrombolysis in SUNSET sPE

Efthymios Avgerinos (University of Pittsburgh, Pittsburgh, USA) presented results from the SUNSET sPE trial during a late-breaking data session at this year’s Vascular Interventional...

SUNSET sPE thrombolysis trial completes enrolment phase

The “Standard versus ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism” (SUNSET sPE) trial, a randomised, single-blinded clinical trial comparing ultrasound-assisted thrombolysis (USAT) to standard...
EXTRACT-PE

EXTRACT-PE an “important first study” for aspiration thrombectomy in acute PE...

Akhilesh Sista (New York, USA) talks to Interventional News at  VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about the results of the EXTRACT-PE study, that were presented in a late-breaking...

VIVA 2019: Penumbra Indigo Aspiration system IDE trial for acute PE...

Penumbra today announced that the EXTRACT-PE trial successfully met the primary endpoints, demonstrating the safety and efficacy of the Indigo Aspiration system for aspiration...

Thrombolex announces first enrolment in early feasibility and safety study using...

Thrombolex has announced the enrolment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir Endovascular Catheter for the treatment...

Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice

 At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

One-year OPTALYSE PE results reinforce safety and efficacy of shorter, lower...

The study results with the Ekos system (BTG) were presented at the International Society on Endovascular Therapy (ISET; 3–7 February 2018, Florida, USA). The findings...
Interventional News for specialists

BTG receives US FDA 510(k) clearance for Ekos control unit 4.0

BTG has announced that US FDA 510(k) clearance has been granted to the Ekos control unit 4.0. The Ekos system includes an ultrasonic device...

First US commercial placements of Angel catheter

Bio2 Medical has announced that the Angel catheter, a new device for the prevention of pulmonary embolism, was placed in two patients at St...